Clinical Dilemmas and a Review of Strategies to Manage Drug Shortages
- 3 April 2013
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 26 (3), 183-191
- https://doi.org/10.1177/0897190013482332
Abstract
Objective: The objectives of this article are to review the clinical implications of drug shortages highlighting patient safety, sedation, and oncology and introduce an expanded phase approach for the management of drug shortages. Data Sources: Literature retrieval was accessed through a PubMed search of English-language sources from January 1990 through April 2012 using the medical subject heading pharmaceutical preparations/supply and distribution and the general search term drug shortages. Study Selection and Data Extraction: All original prospective and retrospective studies, peer-reviewed guidelines, consensus statements, and review articles were evaluated for inclusion. Relevance was determined considering the therapeutic class, focus on drug shortages, and manuscript type. Data Synthesis: The increased number of drug shortages has created significant challenges for health care providers. Two particularly vulnerable populations are critically ill and oncology patients. A lack of therapeutic alternatives in critically ill patients may impact patient safety as well as treatment outcomes. Similarly, a chemotherapy agent in short supply may contribute to adverse outcomes in oncology patients. Conclusions: The mounting number of drug shortages has created a health care crisis, requiring changes in management strategies as well as clinical practice. The expanded phased approach outlined here provides a consistent, systematic approach for the management of drug shortages.Keywords
This publication has 26 references indexed in Scilit:
- Weighing the Costs and Benefits of a SedativeJama-Journal Of The American Medical Association, 2012
- Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancerInternational Journal of Cancer, 2010
- Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unitCritical Care Medicine, 2010
- Use of intravenous infusion sedation among mechanically ventilated patients in the United States*Critical Care Medicine, 2009
- ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health SystemsAmerican Journal of Health-System Pharmacy, 2009
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyAnnals of Oncology, 2008
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation*Critical Care Medicine, 2008
- A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients*Critical Care Medicine, 2006
- Prolonged sedation of critically ill patients with midazolam or propofolCritical Care Medicine, 1997